Patel Dinesh V Ph D: insider trades.
Patel Dinesh V Ph D reported 11 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($33.1M), across 1 company.
- Transactions
- 11
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- PATEL DINESH V PH D
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | Director, Officer · President and CEO | 11 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-10 | Protagonist Therapeutics, Inc | M | 7,278 | $21.58 | 530,246 | Form 4 |
| 2026-09-10 | Protagonist Therapeutics, Inc | S | 7,278 | $144.1 | 522,968 | Form 4 |
| 2026-09-09 | Protagonist Therapeutics, Inc | S | 63,548 | $146.18 | 522,968 | Form 4 |
| 2026-09-09 | Protagonist Therapeutics, Inc | M | 63,548 | $21.58 | 586,516 | Form 4 |
| 2026-09-08 | Protagonist Therapeutics, Inc | S | 54,174 | $145.87 | 522,968 | Form 4 |
| 2026-09-08 | Protagonist Therapeutics, Inc | M | 54,174 | $21.58 | 577,142 | Form 4 |
| 2026-09-03 | Protagonist Therapeutics, Inc | G | 510 | $0 | 522,968 | Form 4 |
| 2026-08-11 | Protagonist Therapeutics, Inc | S | 34,239 | $148.52 | 523,478 | Form 4 |
| 2026-08-11 | Protagonist Therapeutics, Inc | M | 34,239 | $21.58 | 557,717 | Form 4 |
| 2026-08-10 | Protagonist Therapeutics, Inc | M | 65,761 | $21.58 | 589,239 | Form 4 |
| 2026-08-10 | Protagonist Therapeutics, Inc | S | 65,761 | $149.11 | 523,478 | Form 4 |
Questions
What stock did Patel Dinesh V Ph D buy or sell?
Patel Dinesh V Ph D reported 11 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($33.1M), across 1 company.
Is Patel Dinesh V Ph D the same person as other filers with this name?
This page covers SEC CIK 1120477 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/patel-dinesh-v-ph-d-1120477.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.